Literature DB >> 4208360

Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.

J S Meyer, N T Mathew, A Hartmann, V M Rivera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4208360     DOI： 10.1002/j.1552-4604.1974.tb02314.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  8 in total

1.  Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.

Authors:  Jozef J P Nauta
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

Review 2.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

3.  The effect of betahistine methanesulphonate upon cerebral blood flow.

Authors:  R J Hughes; I M James; A Djiane
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

4.  Inhibitory effect of betahistine on polysynaptic neurons in the lateral vestibular nucleus.

Authors:  H Unemoto; M Sasa; S Takaori; J Ito; I Matsuoka
Journal:  Arch Otorhinolaryngol       Date:  1982

Review 5.  Antivertigo medications and drug-induced vertigo. A pharmacological review.

Authors:  O Rascol; T C Hain; C Brefel; M Benazet; M Clanet; J L Montastruc
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

6.  Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease.

Authors:  Augusto Pietro Casani; Elena Navari; Giorgio Guidetti; Michel Lacour
Journal:  Int J Otolaryngol       Date:  2018-10-25

7.  Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.

Authors:  D Monzani; M R Barillari; M Alicandri Ciufelli; E Aggazzotti Cavazza; V Neri; L Presutti; E Genovese
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-12       Impact factor: 2.124

8.  Betahistine in the treatment of Ménière's disease.

Authors:  Michel Lacour; Paul H van de Heyning; Miroslav Novotny; Brahim Tighilet
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.